ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,584.54
      -0.88%
      US Tech 100
      19,681.20
      -2.17%
      Dow Jones
      39,753.75
      0.08%
      Brent Oil
      85.20
      0.11%
      Bitcoin
      56,994.76
      -0.62%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. Aeolus Pharmaceuticals Inc (CE) (AOLS)

      7. Aeolus Pharmaceuticals Inc (CE) (AOLS) News

      AOLS

      Aeolus Pharmaceuticals (CE) (AOLS)

      Aeolus Pharmaceuticals Inc (CE)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:AOLS
      DateTimeSourceHeadlineSymbolCompany
      12:21PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing
      10/24/20119:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      10/24/20119:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      10/24/20119:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      10/24/201110:02AMMarketwiredAeolus to Present at the 10th Annual BIO Investor ForumUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      10/24/20117:01AMMarketwiredAeolus Pharmaceuticals Announces NIH Counteract Grant Award to Develop AEOL 10150 as a Treatment Against Nerve Agent ExposureUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      10/10/201111:55AMMarketwiredAeolus Pharmaceuticals Announces $12.7 Million NIH Counteract Grant Award to Continue Development of AEOL 10150 as a Treatmen...USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      10/05/201111:28AMMarketwiredRoth Capital Initiates Equity Research Analyst Coverage on AeolusUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      09/23/20111:22PMMarketwiredAeolus Pharmaceuticals Files Request for Orphan Drug Designation of AEOL 10150 for Mitigation, and/or Treatment of Delayed Ef...USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      09/12/20116:01AMEdgar (US Regulatory)Amended Quarterly Report (10-Q/A)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      09/06/20115:41PMMarketwiredAeolus to Present at Stifel Nicolaus' Annual Healthcare ConferenceUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      09/01/201111:16AMMarketwiredAeolus Pharmaceuticals' Announces Presentation of AEOL10150 Data at the 14th International Congress of Radiation ResearchUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/29/20112:33PMMarketwiredLadenburg Thalmann Initiates Equity Research Analyst Coverage on AeolusUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/15/20115:28PMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/15/20115:24PMEdgar (US Regulatory)Current report filing (8-K)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      08/15/20114:56PMMarketwiredAeolus Pharmaceuticals Announces Third Quarter Fiscal Year 2011 ResultsUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      07/08/20116:13AMEdgar (US Regulatory)Current report filing (8-K)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      06/13/20114:08PMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/26/20117:32PMMarketwiredNoble Financial Initiates Equity Research Analyst Coverage on AeolusUSOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/24/20117:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      05/16/20114:44PMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      04/18/20112:07PMEdgar (US Regulatory)Current report filing (8-K)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      03/24/20116:03AMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      03/18/201112:40PMEdgar (US Regulatory)Current report filing (8-K)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      03/17/20115:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      03/15/20114:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/25/20114:43PMEdgar (US Regulatory)Current report filing (8-K)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/22/20119:38PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/22/20111:23PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
      02/18/20117:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AOLSAeolus Pharmaceuticals Inc (CE)
       Showing the most relevant articles for your search:USOTC:AOLS

      Your Recent History

      BIT
      UC610C
      Unicredit Bank
      Delayed Upgrade Clock